Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cyanotech Corporation
Cyanotech Names Andrew Jacobson as President & CEO
June 8th, 2008
Cyanotech Corporation (Nasdaq: CYAN), a world leader in producing high-value nutrition and health products from microalgae, announced that its Board of Directors has named Andrew H. Jacobson, age 46, as president and chief executive officer, and a director, effective May 16, 2008. Mr. Jacobson succeeds Gerald R. Cysewski, Ph.D., who was president and chief executive officer. Dr. Cysewski was named executive vice president and chief scientific officer focusing on microalgae product development. He continues as a director. Dr. Cysewski, who is credited with commercializing the large-scale production of microalgae, founded Cyanotech in 1983. Cyanotech's...
Source: Pharma Investments, Ventures & Law Weekly (2008-06-08)
|
